NBC Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

NBC Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293K	Sell	1,850 -886	-32%	-$120K	0.02%	716
2026 Q1	$350K	Sell	2,736 -50	-2%	-$6.24K	0.03%	647
2025 Q4	$340K	Sell	2,786 -1,883	-40%	-$216K	0.03%	640
2025 Q3	$468K	Sell	4,669 -299	-6%	-$26.9K	0.04%	525
2025 Q2	$412K	Buy	4,968 +241	+5%	+$19.2K	0.03%	560
2025 Q1	$383K	Buy	4,727 +4,723	+118,075%	+$422K	0.03%	545
2024 Q4	$437	Sell	4 -5,248	-100%	-$508K	0.04%	493
2024 Q3	$518K	Sell	5,252 -220	-4%	-$21.6K	0.04%	448
2024 Q2	$507K	Sell	5,472 -193	-3%	-$17.3K	0.05%	432
2024 Q1	$537K	Sell	5,665 -175	-3%	-$16.2K	0.05%	413
2023 Q4	$521K	Buy	5,840 +219	+4%	+$16.3K	0.05%	401
2023 Q3	$410K	Buy	+5,621	New	+$449K	0.05%	444

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

NBC Securities's XBI Position: Q2 2026 in Review

NBC Securities reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 32% in Q2 2026, selling an estimated $120K and leaving 1,850 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #716.

NBC Securities first reported a position in XBI in Q3 2023 and has held it in 12 quarters since. The position peaked at $537K in Q1 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

NBC Securities held 1,850 shares of State Street SPDR S&P Biotech ETF worth $293K as of Q2 2026.
NBC Securities sold 886 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $120K.
State Street SPDR S&P Biotech ETF made up 0.02% of NBC Securities's portfolio in Q2 2026, its #716 holding.
NBC Securities first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 12 quarters since.
NBC Securities's State Street SPDR S&P Biotech ETF position peaked at $537K in Q1 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.